Intellipharmaceutics International Inc. (NASDAQ:IPCIF) | WebDisclosure

Basculer en Français

8295	Companies
114858	Keywords
55302	Articles
62445	Press releases

Headlines Articles Press releases Intellipharmaceutics International Inc.

Home
Companies
Intellipharmaceutics International Inc.

BRIEF

published on 06/14/2024 at 22:41, 5 months 6 days ago

Intellipharmaceutics annonce un passage au marché OTC Expert

Commission Des Valeurs Mobilières De L'Ontario Intellipharmaceutique Interdiction D'opérations Sur Opérations Marché Des Experts OTC Formulaire 20-F
BRIEF

published on 06/14/2024 at 22:41, 5 months 6 days ago

Intellipharmaceutics Announces Downgrade to OTC Expert Market

Cease Trade Order Ontario Securities Commission Form 20-F Intellipharmaceutics OTC Expert Market
PRESS RELEASE

published on 06/14/2024 at 22:36, 5 months 6 days ago

Intellipharmaceutics Announces Downgrade to OTC Expert Market
Intellipharmaceutics International Inc. faces downgrade to OTC Expert Market due to filing default. Cease trade order from Ontario Securities Commission also in effect

Intellipharmaceutics International Inc. Pharmaceutical Company Cease Trade Order OTC Expert Market Filing Default
BRIEF

published on 03/13/2024 at 22:20, 8 months 7 days ago

Intellipharmaceutics International Inc. passe à NEX avec un nouveau régime d'options d'achat d'actions

Conformité Réglementaire NEX Intellipharmaceutique International Inc. Plan D'options D'achat D'actions Marché OTCQB
BRIEF

published on 03/13/2024 at 22:20, 8 months 7 days ago

Intellipharmaceutics International Inc. Moves to NEX with New Stock Option Plan

Intellipharmaceutics International Inc. Regulatory Compliance Stock Option Plan NEX OTCQB Marketplace
PRESS RELEASE

published on 03/13/2024 at 22:15, 8 months 7 days ago

Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
Intellipharmaceutics International Inc. announces listing transfer from TSX to NEX due to Cease Trade Order, new stock option plan approved. Company specializes in controlled-release drugs

Intellipharmaceutics International Inc. Cease Trade Order Stock Option Plan NEX Listing Transfer
BRIEF

published on 03/06/2024 at 20:50, 8 months 14 days ago

Intellipharmaceutics Faces Regulatory Challenges With Cease Trade Order

Regulatory Compliance Pharmaceuticals Cease Trade Order Intellipharmaceutics Investor Concerns
BRIEF

published on 03/06/2024 at 20:50, 8 months 14 days ago

Intellipharmaceutics fait face à des défis réglementaires avec une ordonnance d'interdiction d'opérations

Conformité Réglementaire Intellipharmaceutique Ordonnance D’interdiction D’opérations Médicaments Préoccupations Des Investisseurs
PRESS RELEASE

published on 03/06/2024 at 20:45, 8 months 14 days ago

Intellipharmaceutics Announces Cease Trade Order
Intellipharmaceutics International Inc. faces cease trade order for failure to file financial statements with Ontario Securities Commission. Company working on Required Filings

Financial Statements Intellipharmaceutics International Inc. Pharmaceutical Company Cease Trade Order OSC
PRESS RELEASE

published on 02/27/2024 at 01:38, 8 months 23 days ago

Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
Intellipharmaceutics International Inc. announces delay in filing annual audited financial statements for the fiscal year ended November 30, 2023, due to applicable Canadian securities laws. Company working to expedite filing for compliance with OSC regulations

Intellipharmaceutics International Inc. Canadian Securities Laws Filing Delay Annual Audited Financial Statements OSC Regulations

Accesswire

Published on 11/21/2024 at 12:00, 30 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 30 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 27 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 30 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:15, 15 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 23 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 30 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 29 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 32 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 32 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 32 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 22 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 10 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE